NCT06225336View on ClinicalTrials.gov

Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia)

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 4, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Microtia
Interventions
COMBINATION_PRODUCT

AUR-201

Auricle and wedge subcutaneous implant consisting of 3-D printed autologous auricular sourced chondrocytes in a biopolymer matrix.

Trial Locations (1)

2050

Chris O'Brien Lifehouse, Camperdown

Sponsors
All Listed Sponsors
lead

Auregen Biotherapeutics, SA

INDUSTRY

NCT06225336 - Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia) | Biotech Hunter | Biotech Hunter